ITGB2 and breast carcinoma: Previous studies indicated that ITGB2‐AS1 could promote progression, migration and invasion in many types of cancers, including pancreatic ductal adenocarcinoma, renal cell carcinoma, osteosarcoma and breast cancer.15, 16, 17, 18